Form 8-K - Current report:
SEC Accession No. 0001193125-26-005486
Filing Date
2026-01-07
Accepted
2026-01-07 08:30:12
Documents
12
Period of Report
2026-01-07
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20260107.htm   iXBRL 8-K 58352
2 EX-99.1 acet-ex99_1.htm EX-99.1 41700
3 GRAPHIC img94724212_0.jpg GRAPHIC 5549
  Complete submission text file 0001193125-26-005486.txt   225155

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20260107.xsd EX-101.SCH 26202
14 EXTRACTED XBRL INSTANCE DOCUMENT acet-20260107_htm.xml XML 4753
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 26514079
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)